Business Context and Reporting Period
Company: MOOG INC.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2007 (Second Quarter of Fiscal Year 2007)
Business Overview: Moog is a global designer and manufacturer of high-performance precision motion and fluid controls for aerospace, defense, industrial, and medical markets. The company operates through five segments: Aircraft Controls, Space and Defense Controls, Industrial Controls, Components, and Medical Devices.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended Mar 31, 2007 |
Three Months Ended Apr 1, 2006 |
Six Months Ended Mar 31, 2007 |
Six Months Ended Apr 1, 2006 |
|---|---|---|---|---|
| Net Sales | $384,914 | $322,109 | $740,895 | $632,280 |
| Gross Profit | $128,489 | $103,898 | $249,171 | $204,495 |
| Gross Margin | 33.4% | 32.3% | 33.6% | 32.3% |
| Net Earnings | $24,487 | $21,462 | $48,551 | $38,259 |
| Diluted EPS | $0.57 | $0.53 | $1.13 | $0.96 |
| Operating Cash Flow (6mo) | $25,670 (2007) vs $26,173 (2006) | |||
| Total Debt (Long-term + Current) | $487,809 (Mar 31, 2007) vs $380,558 (Sep 30, 2006) | |||
| Cash and Equivalents | $46,453 (Mar 31, 2007) vs $57,821 (Sep 30, 2006) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 19% in the quarter and 17% year-to-date compared to the prior year. Growth was driven by all segments, with recent acquisitions contributing $12 million in the quarter and $23 million year-to-date.
- Profitability: Net earnings rose 14% in the quarter and 27% year-to-date. Gross margins improved due to favorable product mix and lower contract loss reserves ($1 million in Q2 2007 vs. $4 million in Q2 2006).
- Acquisitions: Significant M&A activity included the acquisition of ZEVEX International, Inc. ($82 million net purchase price) in March 2007, expanding the Medical Devices segment. A ball screw manufacturer was also acquired for approximately $5.5 million.
- Expenses: Research and development expenses increased significantly (60% in the quarter) primarily due to development activities for the Boeing 787 Dreamliner. Interest expense rose due to higher debt levels associated with acquisitions.
- Balance Sheet: Total assets increased to $1.81 billion from $1.61 billion. Goodwill increased by $52 million due to acquisitions. Long-term debt increased by approximately $102 million, primarily to fund the ZEVEX acquisition.
Guidance, Outlook, and Risks
2007 Full-Year Outlook
- Sales: Expected to increase 14% to 16% to approximately $1.5 billion.
- Margins: Operating margins expected to be 13.0% (up from 12.4% in 2006).
- Net Earnings: Projected between $98 million and $102 million.
- Diluted EPS: Expected to increase 16% to 20% to a range of $2.28 to $2.36.
Segment Outlook
- Aircraft Controls: Sales expected to rise 6% to $557 million; margins expected to decline to 11.2% due to high R&D on the 787 program.
- Space and Defense: Sales expected to rise 22% to $180 million; margins expected to improve to 13.1%.
- Medical Devices: First full year of operations; sales expected to be $65 million with a 15.0% operating margin.
Risks and Contingencies
- Customer Concentration: Dependence on major customers like Boeing and Lockheed Martin.
- Government Contracts: Risk of funding reductions, delays, or terminations of military programs (e.g., F-35).
- Acquisition Integration: Risks associated with integrating ZEVEX and other recent acquisitions, including purchase accounting adjustments.
- Debt Covenants: The company maintains a $600 million credit facility with covenants regarding leverage, interest coverage, and capital expenditures. Management states they are currently in compliance.
Investor Verification Checklist
- Acquisition Impact: Verify the integration progress and financial contribution of ZEVEX International, Inc. and McKinley Medical to the Medical Devices segment.
- R&D Spend vs. Production: Monitor the transition of the Boeing 787 program from development to production to confirm the expected decline in R&D expenses and margin recovery in the Aircraft Controls segment.
- Debt Levels: Review the utilization of the $600 million credit facility and the impact of increased interest rates (margin increasing to 125 basis points) on future interest expense.
- Contract Loss Reserves: Track additions to contract loss reserves, particularly in the Aircraft Controls segment, as these can significantly impact earnings volatility.
- Foreign Currency: Assess the impact of foreign currency fluctuations (specifically the Euro) on the Industrial Controls segment, which saw a 40% sales increase attributed to currency strength.